EPA:ALTUV • FR0013345493
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIO-UV GROUP SAS (ALTUV.PA).
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 51.286M 53.27% | 43.134M -15.89% | 39.58M -8.24% | 40.788M 3.05% | 39.655M -2.78% | 42.024M 5.97% | |
| EBITDA YoY % growth | 7.018M 76.64% | 5.697M -18.83% | 5.441M -4.49% | 4.944M -9.13% | 5.356M 8.33% | 5.974M 11.54% | |
| EBIT YoY % growth | 4.132M 314.16% | 2.299M -44.37% | 2.132M -7.26% | 1.854M -13.02% | 2.163M 16.67% | 3.296M 52.38% | |
| Operating Margin | 8.06% | 5.33% | 5.39% | 4.55% | 5.45% | 7.84% | |
| EPS YoY % growth | N/A 165.90% | N/A -43.59% | N/A -54.54% | 0.07 -29.92% | 0.07 | 0.14 100.00% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
9 analysts have analysed ALTUV.PA and the average price target is 2.55 EUR. This implies a price increase of 65.8% is expected in the next year compared to the current price of 1.538.
BIO-UV GROUP SAS (ALTUV.PA) will report earnings on 2026-04-08, after the market close.
The consensus rating for BIO-UV GROUP SAS (ALTUV.PA) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.